Alternative Investments
At Fremoluc, we partner with ambitious companies and visionary leaders to unlock long-term growth. Through carefully selected alternative investments, we back entrepreneurs with patient capital and strategic support, helping them scale sustainably. Our mission is to foster enduring value creation for all stakeholders.
Patient Capital
Your trusted partner in all economic climates and market cycles
Purpose-driven
Supporting companies in building sustainable businesses and integrating ESG principles into their operations and investment decisions
Strong Partnerships
Long-term partnerships with entrepreneurs who share our vision
Diversification
Across sectors and investment strategies
Growth Investor
Supporting growth at every stage of the business journey
Innovation
We believe that innovation fuels sustainable economic growth and drives meaningful societal change
InhaTarget Therapeutics
We support InhaTarget Therapeutics, a spin-off from ULB dedicated to developing innovative inhalation-based treatments for pulmonary diseases, with a particular focus on lung cancer.
Founded in 2019, InhaTarget brings together deep expertise in drug formulation, inhalation delivery, and clinical operations to redefine existing molecules through novel therapeutic approaches.
Vade&Co
Our investment in Vade&Co reflects our commitment to the leisure and entertainment sector and our recognition of the rising demand for high-quality recreational experiences in urban centres.
Vade&Co operates premium leisure destinations, including Brussels Bowling and exclusive snooker clubs, delivering sophisticated entertainment that blends activities with contemporary comfort and classic design.
